Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Sanara MedTech Inc. (SMTI) had Revenue of $86.67M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$86.67M
Net Income	$-9.66M
Cost of Goods Sold	$8.14M
Gross Profit	$78.53M
Operating Expenses	$93.39M
Operating Income	$-6.72M
Non-Operating Income/Expense	$-3.20M
Pre-Tax Income	$-9.91M
Normalized Pre-Tax Income	$-9.91M
Income after Taxes	$-9.91M
Income from Continuous Operations	$-9.91M
Consolidated Net Income/Loss	$-9.91M
Normalized Income after Taxes	$-9.91M
EBIT	$-6.72M
EBITDA	$-1.58M
Weighted-Average Shares Outstanding (Basic)	8.48M
Weighted-Average Shares Outstanding (Diluted)	8.48M
Earnings per Share (EPS) (Basic)	$-1.14
Earnings per Share (EPS) (Diluted)	$-1.14
Balance Sheet Financials
Current Assets	$33.31M
Property, Plant, and Equipment	$0.43M
Long-Term Assets	$54.79M
Total Assets	$88.09M
Current Liabilities	$15.29M
Long-Term Debt	$30.69M
Long-Term Liabilities	$33.89M
Total Liabilities	$49.18M
Common Equity	$38.91M
Tangible Shareholders Equity	$-5.70M
Shareholders Equity	$38.91M
Common Shares Outstanding	8.75M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-0.02M
Cash Flow from Investing Activities	$-6.61M
Cash Flow from Financial Activities	$17.37M
Beginning Cash	$5.15M
End Cash	$15.88M
Increase/Decrease in Cash	$10.73M
Stock-Based Compensation	$4.44M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.18
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.44
Debt to Equity Ratio	0.79
Gross Margin	90.61%
Operating Margin	-7.75%
EBIT Margin	-7.75%
EBITDA Margin	-1.83%
Pre-Tax Profit Margin	-11.44%
Profit Margin	-11.15%
Free Cash Flow	$-0.23M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.98
Inventory Turnover	2.96
Receiveable Turnover	6.96
Days Sales in Receivables	52.43
Return on Equity	-25.47%
Return on Tangible Equity	174.00%
Return on Assets	-11.25%
Return on Investments	-14.24%
Book Value Per Share	$4.45
Free Cash Flow per Share	$-0.03
Operating Cash Flow per Share	$-0.00

Data from Zacks Investment Research, Inc.